InsiderTrades

Form 4 for TMO Thermo Fisher Scientific

Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001127602-24-006575 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-23 2024-02-21 TMO Holmes Joseph R. VP, CAO A - Grant $0.00 +267 1,840 +17% $0
D 2024-02-23 2024-02-21 TMO Holmes Joseph R. VP, CAO A - Grant $0.00 +907 907 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-21 A A 146 $0.00 1,719.15 D — — (F1) Includes 9.7447 shares acquired under the Issuer's employees' stock purchase plan on November 15, 2023.
2 Common Common Stock 2024-02-21 A A 121 $0.00 1,840.15 D — — (F2) Shares represent a performance-based restricted stock unit award granted on February 22, 2023. The Company's Compensation Committee certified the achievement of this award on February 21, 2024. One-third of the shares vest on February 28, 2024 and 2025. The remaining one-third will vest on February 28, 2026, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2023, through to December 31, 2025.
3 Derivative Stock Option (Right to Buy) 2024-02-21 A A 907 $0.00 907 D $552.85 · — to 2032-02-21 907 Common Stock (F3) The option vests in four equal annual installments beginning on February 28, 2025.